Literature DB >> 32270348

Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.

Mei Ye1, Ruigang Han2, Jianwu Shi3, Xunda Wang1, Allan Z Zhao1, Fanghong Li4, Hao Chen5,6.   

Abstract

Breast cancer is the most common cancer in women. Although several studies demonstrated cellular apoptosis susceptibility protein (CAS) involved in the development of breast cancer, the underlying mechanisms of CAS regulating cell processes in the breast cancer remain elusive. In the present study, we explored the possible mechanism of CAS in contributing to the cell proliferation in the breast cancer cell line MCF-7. Knockdown of CAS led to the reduction of cell viability and proliferation. Furthermore, cell cycle was arrested in G0/G1 phase after knocking down CAS with the decrease of cyclinD1. In addition, RNA-seq analysis for the CAS knockdown cells demonstrated that total eleven genes were significantly altered (Fold changes > 2). Of note, the expression of cyp24a1 was dramatically increased in the shCAS cells compared to that of shNC cells as well as confirmed by quantitative real-time polymerase chain reaction (qPCR). These observations clarified the previous conflicting results on the cell fates of the breast cells regulated by CAS and provide new insight into the role of CAS in the development of breast cancer.

Entities:  

Keywords:  Breast cancer; CAS; Cell proliferation

Year:  2020        PMID: 32270348     DOI: 10.1007/s12032-020-01366-w

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  49 in total

1.  Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?

Authors:  Ulvi M Yuksel; Ibrahim Turker; Gulay Dilek; Lutfi Dogan; Mehmet A Gulcelik; Berna Oksuzoglu
Journal:  Oncol Res Treat       Date:  2015-08-10       Impact factor: 2.825

Review 2.  24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

Authors:  Wei Luo; Pamela A Hershberger; Donald L Trump; Candace S Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-08       Impact factor: 4.292

3.  CYP24A1-induced vitamin D insufficiency promotes breast cancer growth.

Authors:  Makoto Osanai; Gang-Hong Lee
Journal:  Oncol Rep       Date:  2016-09-05       Impact factor: 3.906

4.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Authors:  V Baldin; J Lukas; M J Marcote; M Pagano; G Draetta
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

Review 5.  CYP24A1 as a potential target for cancer therapy.

Authors:  Toshiyuki Sakaki; Kaori Yasuda; Atsushi Kittaka; Keiko Yamamoto; Tai C Chen
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

6.  Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing.

Authors:  Qiang Dong; Xiang Li; Cheng-Zhi Wang; Shaohua Xu; Gang Yuan; Wei Shao; Baodong Liu; Yong Zheng; Hailin Wang; Xiaoguang Lei; Zhuqiang Zhang; Bing Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-10       Impact factor: 11.205

7.  The Cellular Apoptosis Susceptibility Protein (CAS) Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis and Cell Proliferation.

Authors:  Prashant Monian; Xuejun Jiang
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

8.  Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC).

Authors:  Juliane Winkler; Stephanie Roessler; Carsten Sticht; Amanda L DiGuilio; Elisabeth Drucker; Kerstin Holzer; Eva Eiteneuer; Esther Herpel; Kai Breuhahn; Norbert Gretz; Peter Schirmacher; Alessandro Ori; Stephan Singer
Journal:  Oncotarget       Date:  2016-04-19

9.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

10.  CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.

Authors:  Ching-Fong Liao; Shue-Fen Luo; Li-Tzu Li; Chuang-Yu Lin; Ying-Chun Chen; Ming-Chung Jiang
Journal:  J Exp Clin Cancer Res       Date:  2008-07-03
View more
  2 in total

1.  Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.

Authors:  Chun-Chao Chang; Wei-Yu Kao; Chih-Yi Liu; Hui-Hsien Su; Yu-An Kan; Pao-Ying Lin; Wei-Chi Ku; Kang-Wei Chang; Ruey-Neng Yang; Chi-Jung Huang
Journal:  Int J Oncol       Date:  2022-04-13       Impact factor: 5.884

2.  Interfering with CSE1L/CAS inhibits tumour growth via C3 in triple-negative breast cancer.

Authors:  Mei Ye; Yufei Chen; Jianni Liu; Jiawei Tian; Xunda Wang; Kin Lam Fok; Jianwu Shi; Hao Chen
Journal:  Cell Prolif       Date:  2022-04-10       Impact factor: 8.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.